Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 65, Issue 6, 2006, Pages 775-780

  Jaakkola, Elisa ^a,b   Herzberg, I ^b   Laiho, K ^d   Barnardo, M C N M ^c   Pointon, J J ^b   Kauppi, M ^d   Kaarela, K ^d   Tuomilehto Wolf, E ^e   Tuomilehto, J ^e   Wordsworth, B P ^b   Brown, M A ^b  

^a VAASA CENTRAL HOSPITAL   (Finland)

^b NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FINLAND; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-B27 ANTIGEN; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK ASSESSMENT; SPONDYLITIS, ANKYLOSING;

EID: 33744499449     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.041103     Document Type: Article

References (43)

1. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
2. Hamersma J, Cardon LR, Bradbury L, Brophy S, van der Horst-Bruinsma I, Calin A, et al. Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum 2001;44:1396-400.
3. Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26.
4. Brewerton DA, Hart FD, Micholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. lancet, 1973;i, 904-7.
5. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704-6.
6. Khan MA, Kushner I, Braun WE, Zachary AA, Steinberg AG. HLA-B27 homozygosity in ankylosing spondylitis: relationship to risk and severity. Tissue Antigens 1978;11:434-8.
7. Suarez-Almazor ME, Russell AS. B27 homozygosity and ankylosing spondylitis. J Rheumatol 1987;14:302-4.
8. Brown MA, Kennedy LG, Darke C, Gibson K, Pile KD, Shatford JL, et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998;41:460-5.
9. Vargas-Alarcon G, Londono JD, Hernandez-Pacheco G, Pacheco-Tena C, Castillo E, Cardiel MH, et al. Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis 2002;61:714-17.
10. La Nasa G, Mathieu A, Mulargia M, Carcassi C, Vacca A, Ledda A, et al. Association of the HLA-A2, CW2, B27, S31, DR2 haplotype with ankylosing spondylitis. A possible role of non-B27 factors in the disease. Dis Markers 1993;11:191-203.
11. Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. Arthritis Rheum 2003;48:1385-9.
12. Siren MK, Sareneva H, Lokki ML, Koskimies S. Unique HLA antigen frequencies in the Finnish population. Tissue Antigens 1996;48:703-7.
13. Varilo T, Savukoski M, Norio R, Santavuori P, Peltonen L, Jarvela I. The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population. Am J Hum Genet 1996;58:506-12.
14. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
15. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
16. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
17. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R. New susceptibility haplotype for type 1 diabetes. DIME Study Group, Lancet, 1989;ii, 299-302.
18. Jaakkola E, Herzberg I, Crane AM, Pointon JJ, Laiho K, Kauppi M, et al. A novel human leucocyte antigen-DRB1 genotyping method based on multiplex primer extension reactions. Tissue Antigens 2004;64:88-95.
19. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
20. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996;58:1323-37.
21. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP, et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989;45:541-6.
22. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002;70:124-41.
23. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000;66:279-92.
24. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988;120:849-52.
25. Lathrop GM, Lalouel JM. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 1984;36:460-5.
26. Skarsvag S, Hansen KE, Holst A, Moen T. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes? Tissue Antigens 1992;40:128-33.
27. De La Concha EG, Fernandez-Arquero M, Martinez A, Vidal F, Vigil P, Conejero L, et al. HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin Exp Immunol 1999;116:516-20.
28. Pollicino T, Pernice F, Campo S, Mesiti O, Misefari V, Pernice M, et al. Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. J Gen Virol 1996;77:1833-6.
29. Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bilti P, et al. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology (Oxford) 2002;41:1375-9.
30. Brown MA, Brophy S, Bradbury L, Hamersma J, Timms A, Laval S, et al. Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum 2003;48:2234-9.
31. Saraux A, de Saint-Pierre V, Baron D, Valls I, Koreichi D, Youinou P, et al. The HLA B27 antigen-spondylarthropathy association. Impact on clinical expression. Rev Rhum Engl Ed 1995;62:487-91.
32. Feldtkeller E, Khan MA, Van Der Heijde D, Van Der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23:61-6.
33. Queiro R, Torre JC, Gonzalez S, Lopez-Larrea C, Tinture T, Lopez-Lagunas I. HLA Antigens may influence the age of onset of psoriasis and psoriatic arthritis. J Rheumatol 2003;30:505-7.
34. Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281-6.
35. Ploski R, Flato B, Vinje O, Maksymowych W, Forre O, Thorsby E. Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Hum Immunol 1995;44:88-96.
36. Maksymowych WP, Gorodezky C, Olivo A, Alaez C, Wong C, Burgos-Vargas R, et al. HLA-DRB1*08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J Rheumatol 1997;24:904-7.
37. Calin A, Elswood J. The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis - one disease process or several? Br J Rheumatol 1988;27:393-5.
38. Khan MA, Kushner I, Braun WE. Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 1977;20:909-12.
39. Saari M, Vuorre I, Kaila J, Lahti R. Family studies of ocular manifestations in arthritis. Can J Ophthalmol 1978;13:144-51.
40. Monowarul Islam SM, Numaga J, Fujino Y, Masuda K, Ohda H, Hirata R, et al. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum 1995;38:547-50.
41. Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol 2001;28:2283-8.
42. Westman P, Partanen J, Leirisalo-Repo M, Koskimies S. Different DRB1*04 alleles predominate in the Finnish random population and in HLA-B27-positive subpopulations. Tissue Antigens 1994;44:329-31.
43. Robinson WP, van der Linden SM, Khan MA, Rentsch HU, Cats A, Russell A, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum 1989;32:1135-41.